Schizophrenia and Bipolar Disorder: Tackling Challenges & New Therapeutic Updates



Date & Location
Wednesday, March 22, 2023, 3:00 AM - Thursday, March 21, 2024, 11:59 PM

Credits
AMA PRA Category 1 Credits™ (0.50 hours), AMA PRA Category 1 Credits™ Designated (0.50 hours)

Target Audience
Specialties - Neurology and Rehabilitation, Psychiatry and Behavioral Health
Professions - Advanced Practice Provider (APP), Licensed Therapists/Social Worker, Non-Physician, Nurse, Other Healthcare Professionals, Physician, Physicians In Training, Psychologist

Overview
Schizophrenia affects an estimated 21 million people worldwide, and bipolar disorder (BPD) is the sixth leading cause of disability. These are chronic psychiatric illnesses that require long-term care, and place significant health and economic burdens on patients and their families. In recent decades, the distinct separation of these two illnesses has weakened, and the medical literature now recognizes a partial genetic overlap between schizophrenia and BPD. Unfortunately, both schizophrenia and BPD are difficult to treat and are associated with substantial morbidity and mortality, particularly when sub-optimally treated. Lack of consistent adherence to treatment is a significant issue; however, newer formulations have recently been approved and emerging therapies are on the horizon.

Registration

There are no fees for participating in and receiving CME credit for this online activity.

To participate in this activity, register with ReachMD.


Objectives
As a result of participating in this activity, participants should be able to:

  1. Recognize risk factors to improve adherence associated with schizophrenia and/or bipolar disorder;
  2. Identify newer and emerging agents seeking to improve outcomes in patients with schizophrenia and/or bipolar disorder;
  3. Assess strategies and techniques to collaboratively engage in shared decision making in schizophrenia and bipolar disorder.

Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and CORE Medical Education, LLC. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.

The University of Cincinnati designates this enduring material activity for a maximum of .50 AMA PRA Category 1 Credit™. Physicians should claim only the credits commensurate with the extent of their participation in the activity.

Additional Information
Disclosure of Ineligible Relationships (COI) Policy

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education and the University of Cincinnati policy, all faculty, planning committee members, and other individuals, who are in a position to control content, are required to disclose all relationships with ineligible companies* (commercial interests) within the last 24 months. All educational materials are reviewed for fair balance, scientific objectivity, and levels of evidence. The ACCME requires us to disqualify from involvement in the planning and implementation of accredited continuing education any individuals (1) who refuse to provide this information or (2) whose conflicts of interests cannot be mitigated.

All relevant relationships have been mitigated. The following disclosures were made:

Medical Director & Program Planners

CORE Medical Education, LLC

Otto Ratz, MD
Christina Culbert, MSc

CORE Medical Education staff do not have any relationships to report.

University of Cincinnati Center for Continuous Professional Development/CME

Bruce Gebhardt, MD, Physician Reviewer
Susan P. Tyler, PhD, Associate Dean
Heather Muskopf, Program Manager

University of Cincinnati staff do not have any relationships to report.

Disclaimer Statement
The opinions expressed during the endured activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati or CORE Medical Education. The information is presented for the purpose of advancing the attendees’ professional development.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Neither the University of Cincinnati nor CORE Medical Education, LLC, recommends the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Learner Assurance Statement
The University of Cincinnati is committed to mitigating all conflicts of interest issues that could arise as a result of prospective faculty members’ relationships with ineligible companies. The University of Cincinnati is committed to retaining only those speakers with financial interests that can be mitigated as they relate to the goals and educational integrity of the CME activity.